GHA
AMGN icon

GW Henssler & Associates’s Amgen AMGN Stock Holding History

GW Henssler & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20M Sell
56,962
-1,087
-2% -$388K 0.94% 39
2025
Q4 		$19M Sell
58,049
-1,560
-3% -$495K 0.91% 43
2025
Q3 		$16.8M Sell
59,609
-348
-0.6% -$101K 0.84% 49
2025
Q2 		$16.7M Buy
59,957
+113
+0.2% +$32K 0.89% 48
2025
Q1 		$18.6M Sell
59,844
-30,579
-34% -$9.03M 1.07% 37
2024
Q4 		$29.1M Sell
90,423
-1,373
-1% -$407K 1.67% 19
2024
Q3 		$29.6M Sell
91,796
-762
-0.8% -$249K 1.67% 19
2024
Q2 		$28.9M Sell
92,558
-2,100
-2% -$617K 1.74% 17
2024
Q1 		$26.9M Sell
94,658
-505
-0.5% -$148K 1.58% 20
2023
Q4 		$27.4M Sell
95,163
-1,796
-2% -$489K 1.81% 14
2023
Q3 		$26.1M Sell
96,959
-874
-0.9% -$218K 1.78% 13
2023
Q2 		$21.7M Buy
97,833
+809
+0.8% +$188K 1.43% 30
2023
Q1 		$23.5M Buy
97,024
+1,310
+1% +$322K 1.56% 22
2022
Q4 		$25.1M Sell
95,714
-149
-0.2% -$39.9K 1.77% 17
2022
Q3 		$21.6M Buy
95,863
+2,096
+2% +$508K 1.62% 22
2022
Q2 		$22.8M Buy
93,767
+1,636
+2% +$401K 1.69% 20
2022
Q1 		$22.3M Buy
92,131
+6,458
+8% +$1.48M 1.35% 25
2021
Q4 		$19.3M Sell
85,673
-544
-0.6% -$115K 1.23% 29
2021
Q3 		$18.3M Buy
86,217
+6,898
+9% +$1.59M 1.27% 31
2021
Q2 		$19.3M Buy
79,319
+2,322
+3% +$571K 1.27% 32
2021
Q1 		$19.2M Buy
76,997
+2,470
+3% +$589K 1.37% 26
2020
Q4 		$17.1M Buy
74,527
+1,233
+2% +$284K 1.31% 30
2020
Q3 		$18.6M Buy
73,294
+724
+1% +$179K 1.58% 19
2020
Q2 		$17.1M Buy
72,570
+5,451
+8% +$1.24M 1.5% 28
2020
Q1 		$13.6M Buy
67,119
+14,384
+27% +$3.14M 1.38% 34
2019
Q4 		$12.7M Buy
52,735
+3,795
+8% +$837K 1.05% 38
2019
Q3 		$9.47M Buy
+48,940
New +$9.39M 0.84% 52
2018
Q4 		– Sell
-1,162
Closed -$241K – 122
2018
Q3 		$241K Sell
1,162
-20
-2% -$3.94K 0.02% 127
2018
Q2 		$218K Buy
+1,182
New +$209K 0.02% 121
2017
Q4 		– Sell
-1,182
Closed -$220K – 144
2017
Q3 		$220K Sell
1,182
-34
-3% -$6.02K 0.02% 129
2017
Q2 		$209K Buy
+1,216
New +$198K 0.02% 135
2016
Q4 		– Sell
-2,682
Closed -$447K – 142
2016
Q3 		$447K Sell
2,682
-30
-1% -$5.07K 0.05% 112
2016
Q2 		$413K Buy
2,712
+83
+3% +$12.9K 0.05% 112
2016
Q1 		$394K Sell
2,629
-714
-21% -$106K 0.05% 113
2015
Q4 		$543K Buy
3,343
+766
+30% +$120K 0.06% 112
2015
Q3 		$356K Hold
2,577
– – 0.04% 124
2015
Q2 		$396K Buy
2,577
+75
+3% +$12K 0.04% 119
2015
Q1 		$400K Hold
2,502
– – 0.05% 128
2014
Q4 		$398K Buy
2,502
+158
+7% +$24.6K 0.04% 125
2014
Q3 		$329K Hold
2,344
– – 0.04% 121
2014
Q2 		$277K Sell
2,344
-638
-21% -$73.9K 0.03% 125
2014
Q1 		$368K Sell
2,982
-150
-5% -$18.2K 0.04% 126
2013
Q4 		$357K Hold
3,132
– – 0.04% 127
2013
Q3 		$350K Buy
3,132
+30
+1% +$3.25K 0.05% 118
2013
Q2 		$306K Buy
+3,102
New +$322K 0.04% 123

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

GW Henssler & Associates's AMGN Position: Q1 2026 in Review

GW Henssler & Associates reduced its Amgen (AMGN) stake by 1.9% in Q1 2026, selling an estimated $388K and leaving 56,962 shares worth $20M. The position accounts for 0.94% of the portfolio, ranked #39.

GW Henssler & Associates first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $29.6M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • GW Henssler & Associates held 56,962 shares of Amgen worth $20M as of Q1 2026.
  • GW Henssler & Associates sold 1,087 Amgen shares in Q1 2026, an estimated $388K.
  • Amgen made up 0.94% of GW Henssler & Associates's portfolio in Q1 2026, its #39 holding.
  • GW Henssler & Associates first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
  • GW Henssler & Associates's Amgen position peaked at $29.6M in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on GW Henssler & Associates's 13F filing for Q1 2026, filed 15 May 2026.